Indeed, we have analyzed the ability of differential diagnostic power with levels of IL-7R among healthy subjects, pancreatic cancer, and other pancreatic diseases (e.g., chronic pancreatitis) for a large-scale validation and found the higher differential levels between the diseases. Here, IL7R is linked to familial pancreatic carcinoma.